| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/07/2013 | WO2013032231A2 Pharmaceutical anti-angiogenic composition including a microrna-382 inhibitor |
| 03/07/2013 | WO2013032230A2 Pharmaceutical angiogenic composition including a microrna-382 activator |
| 03/07/2013 | WO2013032184A2 Composition comprising pyrazino-triazine derivatives |
| 03/07/2013 | WO2013032102A1 Fermented gui pi tang product and usage thereof |
| 03/07/2013 | WO2013031930A1 Imine derivative |
| 03/07/2013 | WO2013031729A1 Prophylactic/therapeutic agent for cardiovascular complications of diabetes |
| 03/07/2013 | WO2013030802A1 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| 03/07/2013 | WO2013030725A1 Methods for treating cardiovascular disorders |
| 03/07/2013 | WO2013030564A1 Vascular treatments |
| 03/07/2013 | WO2013030367A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | WO2013030366A1 Novel soft rock inhibitors |
| 03/07/2013 | WO2013030365A1 Novel rock kinase inhibitors |
| 03/07/2013 | WO2013030288A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | WO2013030218A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | US20130059923 Therapeutic Foam |
| 03/07/2013 | US20130059905 Method of Gene Transfer for the Treatment of Recessive Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) |
| 03/07/2013 | US20130059899 Methods of identifying modulators of gpr17 |
| 03/07/2013 | US20130059897 Rapid release irbesartan-containing pharmaceutical composition |
| 03/07/2013 | US20130059887 Substituted pyridoxine-lactam carboxylate salts |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059858 Benzofuranyl analogues as gpr119 modulators |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | US20130059843 Thiazolyl- and Oxazolyl-Isoquinolinones and Methods for Using Them |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059823 Diazeniumdiolate Cyclohexyl Derivatives |
| 03/07/2013 | US20130059820 Inositol pyrophosphates, and methods of use thereof |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059800 Pyrrolobenzodiazepines used to treat proliferative diseases |
| 03/07/2013 | US20130059786 Compositions and methods for the treatment of cardiac and vascular disease |
| 03/07/2013 | US20130059784 Combination therapies using cyclosporine and aromatic cationic peptides |
| 03/07/2013 | US20130059782 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
| 03/07/2013 | US20130059781 Long-Acting Gastrin Derivatives |
| 03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130059771 Function and Regulation of Angiopoietin-3/Angiopoietin-4 |
| 03/07/2013 | US20130059770 Polypeptides |
| 03/07/2013 | US20130059006 3-dimensional cardiac fibroblast derived extracellular matrix |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058980 Small molecule inhibitors of protein kinases |
| 03/07/2013 | US20130058972 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof |
| 03/07/2013 | US20130058942 Human beta-adrenergic receptor kinase polypeptide and methods |
| 03/07/2013 | US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis |
| 03/07/2013 | US20130058927 Anti-vegf antibodies |
| 03/07/2013 | US20130058919 Optimized Fc Variants and Methods for their Generation |
| 03/07/2013 | US20130058916 Proangiogenic compositions, method for preparing same, and uses thereof |
| 03/07/2013 | US20130058905 Angiohematopoietic Progenitor Cells |
| 03/07/2013 | US20130058904 Method and system for treatment of biological tissue |
| 03/07/2013 | US20130058903 Stem-Cell Material and Method of Use |
| 03/07/2013 | US20130058893 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 03/07/2013 | US20130058868 Method for the treatment of t cell mediated conditions by depletion of icos-positive cells in vivo |
| 03/07/2013 | US20130058866 N-pyrazole a2a receptor agonists |
| 03/07/2013 | DE10213051B4 Substituierte 4-Aminocyclohexanole Substituted 4-aminocyclohexanols |
| 03/07/2013 | CA2847075A1 Substituted annellated pyrimidine and the use thereof |
| 03/07/2013 | CA2847017A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/07/2013 | CA2846752A1 Biphenylcarboxamides as rock kinase inhibitors |
| 03/07/2013 | CA2846695A1 Novel soft rock inhibitors |
| 03/07/2013 | CA2846694A1 Novel rock kinase inhibitors |
| 03/07/2013 | CA2846387A1 Methods for treating cardiovascular disorders |
| 03/07/2013 | CA2845753A1 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension |
| 03/06/2013 | EP2565275A1 Method of treatment of vascular complications using modulators of TRX and TRXNIP |
| 03/06/2013 | EP2565269A1 High-purity soluble thrombomodulin and method for producing same |
| 03/06/2013 | EP2565190A1 Tetrahydrobenzothiophene compound |
| 03/06/2013 | EP2565186A1 Selective and reversible inhibitors of ubiquitin specific protease 7 |
| 03/06/2013 | EP2564900A1 C-19 steroids for therapeutic uses |
| 03/06/2013 | EP2564860A2 Yeast hydrolysate having obesity treatment effects and antioxidant activity |
| 03/06/2013 | EP2564856A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564855A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2564854A1 Treatment of heart failure in non-human mammals with an aldosterone antagonist |
| 03/06/2013 | EP2563785A1 Compounds as agonists of s1p1 receptors |
| 03/06/2013 | EP2563780A1 3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1]oct- 8 - yl) -[5- (1h - pyrazol - 4 -yl) -thiophen-3 -yl]methanones as inhibitors of 11 (beta) -hsd1 |
| 03/06/2013 | EP2563771A2 Metalloenzyme inhibitor compounds |
| 03/06/2013 | EP2563765A1 Bicyclic compound derivatives and their use as acc inhibitors. |
| 03/06/2013 | EP2563398A1 Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans |
| 03/06/2013 | EP2563369A2 Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof |
| 03/06/2013 | CN102958937A Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors |
| 03/06/2013 | CN102958521A Sustained-release therapeutic agent for hypertension and renal dysfunction |
| 03/06/2013 | CN102952775A Method, composition and use of using au nanocluster to relieve oxygen partial pressure and/or aging |
| 03/06/2013 | CN102952716A Dual poris wine and infusing method |
| 03/06/2013 | CN102952714A Licorice and wild jujube wine and infusing method |
| 03/06/2013 | CN102952711A Chinese magnoliavine wine and infusing method |
| 03/06/2013 | CN102952710A Ginseng and radix astragali preparata wine and infusing method thereof |
| 03/06/2013 | CN102952708A Heart nourishing wine and infusing method |
| 03/06/2013 | CN102952695A Jave Amonum Fruit healthcare wine for chest distress |
| 03/06/2013 | CN102952168A Estrogen derivative used as vasoinhibitor, as well as preparation method and medical application thereof |
| 03/06/2013 | CN102952138A Salts and polymorphic substances of pyrazolo pyrimidinone compound, pharmaceutical composition thereof, and preparation method and application thereof |
| 03/06/2013 | CN102952118A Poly(ADP-ribose)polymerase inhibitor, preparation method and application thereof |
| 03/06/2013 | CN102952112A Tricyclic guanidine derivatives as sodium-proton exchange inhibitors |
| 03/06/2013 | CN102952107A High-purity beraprost sodium as well as preparation method and application thereof |
| 03/06/2013 | CN102952104A Furan compound |
| 03/06/2013 | CN102952059A Amide derivative and preparation method thereof, medicine composition and application |
| 03/06/2013 | CN102949726A Medicinal composition |
| 03/06/2013 | CN102949709A External gel used for treating diabetic foot, and preparation method and application thereof |
| 03/06/2013 | CN102949708A Application of human sDR5 (soluble death receptor 5) protein or sDR5-Fc (fragment crystallizable) antibody fusion protein as pharmaceutical drugs for myocardial infarction |
| 03/06/2013 | CN102949649A Traditional Chinese medicine prescription for treating heart disease |
| 03/06/2013 | CN102949648A Traditional Chinese medicine for treating traumatic injury |
| 03/06/2013 | CN102949617A Pill for dredging and dissolving thrombus |